IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intercept Pharmaceuticals in

CUSIP: 45845PAC2 | 14 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Deerfield Management Company, L.P.98,354,000
2.3% of portfolio›$105.1M
Wolverine Asset Management LLC7,792,000
0.1% of portfolio›$8.4M
CSS LLC4,500,000
0.3% of portfolio›$4.8M
Citigroup Inc262,000
0.0% of portfolio›$280.5K
JPMorgan Chase & Co175,000
0.0% of portfolio›$187.7K
Jane Street Group, LLC60,000
0.0% of portfolio›$64.2K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Deerfield Management Company, L.P.
98,354,000$105.1M2.3%YieldMediumNew York, NY2023-11-14
Wolverine Asset Management LLC
7,792,000$8.4M0.1%Deep ValueVery HighChicago, IL2023-11-13
CSS LLC
4,500,000$4.8M0.3%Deep ValueHighChicago, IL2023-11-14
Citigroup Inc
262,000$280.5K0.0%CoreMediumNew York, NY2023-12-06
JPMorgan Chase & Co
175,000$187.7K0.0%GrowthMediumNew York, NY2023-11-14
Jane Street Group, LLC
60,000$64.2K0.0%CoreVery HighNew York, NY2023-11-15
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-10-30